Tissue plasminogen activator
Activase® Alteplase, tPA
Action
Thrombolytic
Status
US FDA approved in acute ischemic stroke within 3 hours of onset, June 1996. Study of tPA with stroke onset 3-5 hours (ATLANTIS) halted 7/98 due to lack of efficacy.
Trial(s)


|